Acura Pharmaceuticals Announces Executive Leadership Transition
Company Announcements

Acura Pharmaceuticals Announces Executive Leadership Transition

Acura Pharmaceuticals (ACUR) has shared an update.

Peter A. Clemens, Sr. Vice President and CFO of Acura Pharmaceuticals, is set to retire on September 30, 2024, with a planned transition period until then. Robert A. Seiser, with the company since 1998 and currently its VP Treasurer and Corporate Controller, will succeed Clemens as the new CFO starting August 1, 2024. This executive shift marks a significant change in Acura’s financial leadership.

See more insights into ACUR stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAcura Pharmaceuticals Secures Loan, Faces Bankruptcy Risk
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App